Cross talk between genetic and epigenetic mechanisms driving prostate ...

Cross talk between genetic and epigenetic mechanisms driving prostate cancer progression from a castration-sensitive prostate cancer (CSPC) to lineage plastic prostate cancer (LP-PCa), which ...

Our increasing understanding of the epigenetic mechanisms driving prostate cancer initiation and progression is fueling development of novel therapeutic strategies that can target these epi-genetic processes.
Prostate Cancer Epigenetics

Alterations in the epigenetic cityscape of prostate cancer cells compared with normal prostate tissues have a complex interplay with genetic alterations to drive prostate cancer initiation and progression. Indeed, mutations in genes encoding epigenetic enzymes are often observed in human cancers including prostate cancer.
Substantial advances in the understanding of epigenetic mechanisms in the pathophysiology of prostate cancer have been carried out, but translating preclinical achievements into clinical practice ...

Prostate Cancer Epigenome
Prostate cancer is a major health burden within the ever-increasingly aging US population. The molecular mechanisms involved in prostate cancer are diverse and heterogeneous. In this context, epigenetic changes, both global and gene specific, are ...
The underlying molecular basis of this resistance mechanism remains incompletely understood, but a suite of epigenetic mechanisms appear to play a central role in establishing, maintaining, and adapting cell-lineage transcriptional programs [6, 10-13].

Epigenetics regulation of prostate cancer
The epigenetic modifications change gene expression levels without altering the nucleotide sequence of the genome and play a vital role in cancer initiation, progression, and decreased sensitivity to treatment. Epigenetics includes 4 important mechanisms (Fig. 2).
Abstract Acquired or inherited genetic alterations either alone or in combination with epigenetic alterations are associated with prostate carcinogenesis and its progression toward advance metastatic or castration-resistant disease.

Deciphering the genetic and epigenetic architecture of prostate cancer
Further, in this chapter we delve into the underlying signaling mechanism , the advancements in targeting genetic and epigenetic alterations in prostate cancer. These findings have revealed promising targets for therapeutic advancements, aiming to understand and identify promising avenues for future therapies.






Prostate cancer is driven by interrelated genetic 1,2 and epigenetic 3 alterations. Known genetic contributors to sporadic prostate cancer are the presence of germline genetic variants that ...